Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 091220

Expand all

GLIMEPIRIDE (GLIMEPIRIDE)
1MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 001
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

GLIMEPIRIDE (GLIMEPIRIDE)
2MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 002
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

GLIMEPIRIDE (GLIMEPIRIDE)
3MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 3MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A091220
Product Number: 003
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

GLIMEPIRIDE (GLIMEPIRIDE)
4MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 004
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

GLIMEPIRIDE (GLIMEPIRIDE)
6MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 6MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A091220
Product Number: 005
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

GLIMEPIRIDE (GLIMEPIRIDE)
8MG
Marketing Status: Prescription

Active Ingredient: GLIMEPIRIDE
Proprietary Name: GLIMEPIRIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091220
Product Number: 006
Approval Date: Jun 29, 2012
Applicant Holder Full Name: MICRO LABS LTD
Marketing Status:  Prescription
Patent and Exclusivity Information